Imbrici P - Search Results

1

ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force.

Tricarico D, Selvaggi M, Passantino G, De Palo P, Dario C, Centoducati P, Tateo A, Curci A, Maqoud F, Mele A, Camerino GM, Liantonio A, Imbrici P, Zizzo N. Tricarico D, et al. Among authors: imbrici p. Front Physiol. 2016 May 10;7:167. doi: 10.3389/fphys.2016.00167. eCollection 2016. Front Physiol. 2016. PMID: 27242541 Free PMC article. Review.

2

Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Imbrici P, Camerino DC, Tricarico D. Imbrici P, et al. Front Genet. 2013 May 7;4:76. doi: 10.3389/fgene.2013.00076. eCollection 2013. Front Genet. 2013. PMID: 23675382 Free PMC article.

3

Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.

Imbrici P, Liantonio A, Gradogna A, Pusch M, Camerino DC. Imbrici P, et al. Biochim Biophys Acta. 2014 Oct;1838(10):2484-91. doi: 10.1016/j.bbamem.2014.05.017. Epub 2014 May 24. Biochim Biophys Acta. 2014. PMID: 24863058 Free article.

4

I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes.

Gradogna A, Imbrici P, Zifarelli G, Liantonio A, Camerino DC, Pusch M. Gradogna A, et al. Among authors: imbrici p. Biochim Biophys Acta. 2014 Nov;1838(11):2745-56. doi: 10.1016/j.bbamem.2014.07.021. Epub 2014 Jul 26. Biochim Biophys Acta. 2014. PMID: 25073071 Free PMC article.

5

Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita.

Portaro S, Altamura C, Licata N, Camerino GM, Imbrici P, Musumeci O, Rodolico C, Conte Camerino D, Toscano A, Desaphy JF. Portaro S, et al. Among authors: imbrici p. Neuromolecular Med. 2015 Sep;17(3):285-96. doi: 10.1007/s12017-015-8356-8. Epub 2015 May 26. Neuromolecular Med. 2015. PMID: 26007199 Free PMC article.

6

Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.

Liantonio A, Imbrici P, Camerino GM, Fracchiolla G, Carbonara G, Giannico D, Gradogna A, Mangiatordi GF, Nicolotti O, Tricarico D, Pusch M, Camerino DC. Liantonio A, et al. Among authors: imbrici p. J Hypertens. 2016 May;34(5):981-92. doi: 10.1097/HJH.0000000000000876. J Hypertens. 2016. PMID: 26991533

7

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Imbrici P, Liantonio A, Camerino GM, De Bellis M, Camerino C, Mele A, Giustino A, Pierno S, De Luca A, Tricarico D, Desaphy JF, Conte D. Imbrici P, et al. Front Pharmacol. 2016 May 10;7:121. doi: 10.3389/fphar.2016.00121. eCollection 2016. Front Pharmacol. 2016. PMID: 27242528 Free PMC article. Review.

8

Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.

Imbrici P, Altamura C, Camerino GM, Mangiatordi GF, Conte E, Maggi L, Brugnoni R, Musaraj K, Caloiero R, Alberga D, Marsano RM, Ricci G, Siciliano G, Nicolotti O, Mora M, Bernasconi P, Desaphy JF, Mantegazza R, Camerino DC. Imbrici P, et al. FASEB J. 2016 Oct;30(10):3285-3295. doi: 10.1096/fj.201500079R. Epub 2016 Jun 20. FASEB J. 2016. PMID: 27324117 Free PMC article.

Furthermore, it could be relevant to the study and therapy of any channelopathy.-Imbrici, P., Altamura, C., Camerino, G. M., Mangiatordi, G. F., Conte, E., Maggi, L., Brugnoni, R., Musaraj, K., Caloiero, R., Alberga, D., Marsano, R. M., Ricci, G., Siciliano, G., Nic …

Furthermore, it could be relevant to the study and therapy of any channelopathy.-Imbrici, P., Altamura, C., Camerino, G. M., M …

9

Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT₁ receptor blockers valsartan and olmesartan.

Imbrici P, Tricarico D, Mangiatordi GF, Nicolotti O, Lograno MD, Conte D, Liantonio A. Imbrici P, et al. Br J Pharmacol. 2017 Jul;174(13):1972-1983. doi: 10.1111/bph.13794. Epub 2017 Apr 26. Br J Pharmacol. 2017. PMID: 28334417 Free PMC article.

10

Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research.

Imbrici P, Conte D, Liantonio A. Imbrici P, et al. J Physiol. 2017 Aug 15;595(16):5403-5404. doi: 10.1113/JP274645. Epub 2017 Jul 7. J Physiol. 2017. PMID: 28598505 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page